Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study.

BMC Cancer · 2018 · PMC5891974 · PMID 29631561

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

borderline significanceP = 0.057so close (0.05 < p ≤ 0.1)

The point estimate of the aHR for hyperlipidemia in the HCV cohort was similar (0.81), but with borderline significance ( P = 0.057; Table 4b ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.